GLATIRAJECT Trademark

Trademark Overview

On Wednesday, March 21, 2012, a trademark application was filed for GLATIRAJECT with the United States Patent and Trademark Office. The USPTO has given the GLATIRAJECT trademark a serial number of 85575338. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 2, 2015. This trademark is owned by Novartis AG. The GLATIRAJECT trademark is filed in the Medical Instrument Products category with the following description:

Injection device for pharmaceuticals
glatiraject

General Information

Serial Number85575338
Word MarkGLATIRAJECT
Filing DateWednesday, March 21, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 2, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 7, 2012

Trademark Statements

Goods and ServicesInjection device for pharmaceuticals

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, March 28, 2012
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, November 2, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 2, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 6, 2015EXTENSION 5 GRANTED
Friday, March 27, 2015EXTENSION 5 FILED
Friday, March 27, 2015TEAS EXTENSION RECEIVED
Thursday, October 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 1, 2014EXTENSION 4 GRANTED
Monday, September 29, 2014EXTENSION 4 FILED
Monday, September 29, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 7, 2014EXTENSION 3 GRANTED
Friday, March 28, 2014EXTENSION 3 FILED
Friday, March 28, 2014TEAS EXTENSION RECEIVED
Thursday, October 3, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 2, 2013EXTENSION 2 GRANTED
Monday, September 30, 2013EXTENSION 2 FILED
Monday, September 30, 2013TEAS EXTENSION RECEIVED
Friday, April 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 11, 2013EXTENSION 1 GRANTED
Thursday, March 21, 2013EXTENSION 1 FILED
Thursday, April 11, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 21, 2013TEAS EXTENSION RECEIVED
Tuesday, October 2, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 7, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 7, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 18, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 27, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 27, 2012ASSIGNED TO EXAMINER
Wednesday, March 28, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 24, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

glatiraject pharmaceuticals device injection